Gene linked to doubling the risk of death due to COVID-19 identified using technology exclusively licensed to Nucleome Therapeutics

Gene linked to doubling the risk of death due to COVID-19 identified using technology exclusively licensed to Nucleome Therapeutics Study conducted by Nucleome's academic founders at the University

Related Keywords

United Kingdom ,Kostenloser Wertpapierhandel ,James Davies ,Danuta Jeziorska ,Oxford Sciences Enterprises ,University Of Oxford ,Consilium Strategic Communications ,Nucleome Therapeutics ,Nature Genetics ,South Asian ,Academic Founder ,Chief Executive Officer ,Oxford Sciences ,Gene ,Inked ,Doubling ,Risk ,Death ,Covid ,Dentified ,Sing ,Technology ,Xclusively ,Icensed ,Nucleome ,Herapeutics ,